MVP — Medical Developments International Income Statement
0.000.00%
Last trade - 00:00
- AU$46.60m
- AU$33.33m
- AU$32.34m
- 22
- 67
- 36
- 39
2019 June 30th | 2020 June 30th | 2021 June 30th | C2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 21.3 | 22.9 | 25.3 | 21.9 | 32.3 |
Cost of Revenue | |||||
Gross Profit | 14.6 | 15.3 | 19.2 | 15.2 | 22.2 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 19.8 | 22.6 | 40.3 | 38.2 | 59.3 |
Operating Profit | 1.55 | 0.321 | -15 | -16.3 | -27 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.55 | 0.321 | -15 | -15.9 | -7.49 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.04 | 0.379 | -12.6 | -12.4 | -5.61 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.04 | 0.379 | -12.6 | -12.4 | -5.61 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.04 | 0.379 | -12.6 | -12.4 | -5.61 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.016 | 0.006 | -0.008 | -0.163 | -0.146 |
Dividends per Share |